1. Home
  2. CRGX vs PFC Comparison

CRGX vs PFC Comparison

Compare CRGX & PFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • PFC
  • Stock Information
  • Founded
  • CRGX 2021
  • PFC 1920
  • Country
  • CRGX United States
  • PFC United States
  • Employees
  • CRGX N/A
  • PFC N/A
  • Industry
  • CRGX
  • PFC Major Banks
  • Sector
  • CRGX
  • PFC Finance
  • Exchange
  • CRGX Nasdaq
  • PFC Nasdaq
  • Market Cap
  • CRGX 964.5M
  • PFC 897.4M
  • IPO Year
  • CRGX 2023
  • PFC N/A
  • Fundamental
  • Price
  • CRGX $12.81
  • PFC $25.99
  • Analyst Decision
  • CRGX Strong Buy
  • PFC Hold
  • Analyst Count
  • CRGX 6
  • PFC 5
  • Target Price
  • CRGX $31.80
  • PFC $23.33
  • AVG Volume (30 Days)
  • CRGX 224.8K
  • PFC 121.7K
  • Earning Date
  • CRGX 11-12-2024
  • PFC 01-21-2025
  • Dividend Yield
  • CRGX N/A
  • PFC 4.63%
  • EPS Growth
  • CRGX N/A
  • PFC N/A
  • EPS
  • CRGX N/A
  • PFC 1.97
  • Revenue
  • CRGX N/A
  • PFC $245,857,000.00
  • Revenue This Year
  • CRGX N/A
  • PFC N/A
  • Revenue Next Year
  • CRGX N/A
  • PFC $7.24
  • P/E Ratio
  • CRGX N/A
  • PFC $13.59
  • Revenue Growth
  • CRGX N/A
  • PFC N/A
  • 52 Week Low
  • CRGX $13.10
  • PFC $18.63
  • 52 Week High
  • CRGX $33.92
  • PFC $29.63
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 30.99
  • PFC 37.61
  • Support Level
  • CRGX $13.33
  • PFC $27.49
  • Resistance Level
  • CRGX $15.26
  • PFC $28.29
  • Average True Range (ATR)
  • CRGX 1.36
  • PFC 0.80
  • MACD
  • CRGX -0.30
  • PFC -0.28
  • Stochastic Oscillator
  • CRGX 3.51
  • PFC 7.36

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About PFC Premier Financial Corp.

Premier Financial Corp is a financial holding company that operates as a community banking and financial services corporation. It offers a broad range of financial services through its subsidiaries including checking accounts, savings accounts, certificates of deposit, real estate mortgage loans, commercial loans, consumer loans, home equity loans, and trust and wealth management services.

Share on Social Networks: